Skip to content

Electroencephalographic Patterns of Septic Patients and Its Correlation With Cognitive Outcomes

Electroencephalographic Patterns of Septic Patients and Its Correlation With Cognitive Outcomes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05448534
Enrollment
160
Registered
2022-07-07
Start date
2021-11-01
Completion date
2023-02-24
Last updated
2023-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Keywords

Eletroencephalography, Sepsis, Septic shock, Critical care, cognitive dysfunction, Montreal cognitive assessment

Brief summary

The investigators evaluated the electroencephalographic pattern by the Sinek and Young scales during ICU stay and its correlation with cognitive impairment determined by the Montreal Cognitive Assessment (MOCA) in septic patients after 3 months of ICU discharge..

Detailed description

The investigators prospectively evaluate patients with sepsis and septic shock expected to stay in the intensive care unit (ICU) for at least 4 days. We used Sinek and Young scales to classify electroencephalographic patterns during ICU stay (in the first 24 hours after admission and in the third ICU day) and correlate with cognitive outcome evaluated with MOCA score 3 months after ICU discharge. The investigators evaluate as primary outcome the association between electroencephalographic abnormalities and cognitive dysfunction measured by the Montreal Cognitive Assessment (MoCA) 3 months after ICU discharge and secondary outcomes as association between electroencephalographic patterns and 28 days mortality, Quality of Life (SF-36) after 3 months of discharge, ventilator free days, vasoactive drug free days and Glasgow outcome scale.

Interventions

DIAGNOSTIC_TESTEletroencephalography

We used Sinek and Young Scale to classify electroencephalographic patterns and cognitive outcome with MOCA score.

Sponsors

Hospital Sao Domingos
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Included were patients aged above 18 years, who were expected to stay in the ICU for at least 4 days, between November 2021 and November 2022. \-

Exclusion criteria

* CNS infections, * Structural abnormalities of the CNS, known * Liver or uremic encephalopathy, * Advanced dementia (Mini mental \< 9), * Psychiatric disorder * Epilepsy.

Design outcomes

Primary

MeasureTime frameDescription
Electroencephalographic patterns3 months after hospital dischargeElectroencephalographic patterns determined by Sinek and Young scales. The Synek outcome Scale ranges from normal (alpha dominant rhythm) to suppression (worst outcome). The scale assesses the outcome of patients with sepsis. Young's Scale Electroencephalographic classification of coma assesses outcome of patients with sepsis Outcome varies from normal (Delta/Theta Rhythm \> 50% of record). worst result Suppression The two scales are complementary.
Cognitive evaluation3 months after hospital dischargeCognitive dysfunction measured by Montreal Cognitive Assessment (MoCA)

Secondary

MeasureTime frameDescription
electroencephalographic patterns and 28 days mortality .28 daysElectroencephalographic patterns determined by Sinel and Young scales and 28 days .mortality. The Synek outcome Scale ranges from normal (alpha dominant rhythm) to suppression (worst outcome). The scale assesses the outcome of patients with sepsis. Young's Scale Electroencephalographic classification of coma assesses outcome of patients with sepsis Outcome varies from normal (Delta/Theta Rhythm \> 50% of record). worst result Suppression The two scales are complementary.
Quality of Life (SF-36) after 3 months of discharge3 months after hospital dischargeQuality of life determined through Short-Form Health Survey (SF-36). Scores range from 0 to 100, 0 indicating the less favorable health status and 100 the most favorable one.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026